Search Orphan Drug Designations and Approvals
-
Generic Name: | nusinersen | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trade Name: | Spinraza | ||||||||||||||||
Date Designated: | 04/18/2011 | ||||||||||||||||
Orphan Designation: | Treatment of spinal muscular atrophy | ||||||||||||||||
Orphan Designation Status: | Designated/Approved | ||||||||||||||||
Sponsor: |
Biogen, Inc 225 Binney Street Cambridge, Massachusetts 02142 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
||||||||||||||||
Marketing approved: |
|||||||||||||||||
1 | Generic Name: | nusinersen |
---|---|---|
Trade Name: | Spinraza | |
Marketing Approval Date: | 12/23/2016 | |
Approved Labeled Indication: | Treatment of spinal muscular atrophy in pediatric and adult patients | |
Exclusivity End Date: | 12/23/2023 | |
Exclusivity Protected Indication* : | Treatment of spinal muscular atrophy in pediatric and adult patients | |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-